Peripheral Arterial Disease Market Report 2026

Peripheral Arterial Disease Market Overview

• Peripheral Arterial Disease market size has reached to $4.74 billion in 2025 • Expected to grow to $7.28 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Growing Prevalence Of Diabetes Is Anticipated To Expand The Peripheral Arterial Diseases • Market Trend: Innovative Shockwave E8 Peripheral IVL Catheter for Treating Peripheral Arterial Disease • North America was the largest region in 2025.

What Is Covered Under Peripheral Arterial Disease Market?

Peripheral arterial disease (PAD) refers to a medical condition characterized by the narrowing or blockage of the arteries that supply blood to the extremities, typically the legs and feet. It is a type of atherosclerosis, which is an accumulation of fat cells (plaque) in the arteries, leading to reduced blood flow. The treatment of the disease involves a combination of lifestyle modifications, medications and medical procedures aimed at increasing blood supply to the affected extremities, providing symptom relief and lowering the risk of consequences. The main treatment types for peripheral arterial disease are devices, catheters, drugs and others. Devices for peripheral artery disease (PAD) refer to medical devices that are used for the diagnosis, treatment and management of the condition. The various routes of administration include oral, parenteral and others. These are used by various end-users such as hospitals, specialty clinics and others.

What Is The Peripheral Arterial Disease Market Growth Forecast?

The peripheral arterial disease market size is expected to see strong growth in the next few years. It will grow to $7.28 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to advancements in minimally invasive endovascular procedures, growing adoption of drug-eluting devices, expansion of hospitals and specialty clinics for PAD care, rising patient awareness about early intervention, increasing use of combination therapies including lifestyle modification and drugs. Major trends in the forecast period include increasing use of ai for early diagnosis and risk assessment, rising adoption of digital and cloud-based patient monitoring systems, growing focus on genomic-based personalized pad treatments, increasing implementation of iot-enabled devices for post-treatment tracking, rising integration of smart manufacturing in pad device production.

Global Peripheral Arterial Disease Market Segmentation

1) By Treatment Type: Devices, Catheters, Drugs, Other Types 2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations 3) By End User: Hospitals, Specialty Clinics, Other End-Users Subsegments: 1) By Devices: Stents, Balloons, Atherectomy Devices 2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires 3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators 4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy

What Is The Driver Of The Peripheral Arterial Disease Market?

The growing prevalence of diabetes is expected to propel the growth of the peripheral arterial disease market going forward. Diabetes refers to a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar). As the prevalence of diabetes increases, so too does the demand for treatments for this condition. The growing prevalence of diabetes is a factor in peripheral arterial disease (PAD). People with diabetes are at a higher risk of developing atherosclerosis, which is the most common cause of PAD and requires treatment. For instance, in March 2024, according to reports published by The Office for Health Improvement and Disparities (OHID), a UK-based government agency, between the 15 months ending in March 2022 and those ending in March 2023, the percentage of individuals with type 1 diabetes who received eight care processes rose by 22%, while for type 2 diabetes, the increase was 21%. Therefore, the growing prevalence of diabetes is driving the growth of the peripheral arterial disease industry.

Key Players In The Global Peripheral Arterial Disease Market

Major companies operating in the peripheral arterial disease market are Johnson and Johnson Limited, Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC

Global Peripheral Arterial Disease Market Trends and Insights

Major companies operating in the peripheral arterial disease market are focused on developing innovative medical devices such as intravascular lithotripsy (IVL) catheter to enhance treatment efficacy, improve patient outcomes, and reduce recovery times for individuals suffering from vascular conditions. Intravascular lithotripsy (IVL) catheter is a medical device used to treat calcified arterial blockages by delivering controlled shockwaves to break down the calcium, helping to restore blood flow and improve vessel flexibility during procedures such as angioplasty. For instance, in September 2024, Shockwave Medical, Inc., a U.S.-based medical technology company, launched the Shockwave E8 peripheral IVL catheter, a medical device designed to treat peripheral arterial disease by delivering targeted intravascular lithotripsy, which uses sonic waves to break down calcium deposits in arterial walls. This innovative approach helps restore blood flow while minimizing trauma to surrounding tissues. The catheter’s advanced design allows for easier navigation through complex vascular anatomy, making it suitable for a wide range of patients.

What Are Latest Mergers And Acquisitions In The Peripheral Arterial Disease Market?

In February 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Cardiovascular Systems Inc. for $890 million. With this acquisition, Abbott aims to strengthen its cardiovascular portfolio and add new complementary technologies. Cardiovascular Systems Inc. is a US-based medical device company that develops and commercializes products for treating peripheral and coronary vascular disease.

Regional Outlook

North America was the largest region in the peripheral artery disease market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Peripheral Arterial Disease Market?

The peripheral artery disease market consists of sales of cardiac medical devices and diagnostic tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Peripheral Arterial Disease Market Report 2026?

The peripheral arterial disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral arterial disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.